EUROFINS SCIENTIFIC (ERF.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:ERF - FR0014000MR3 - Common Stock
ERF.PA Key Statistics, Chart & Performance
The current stock price of ERF.PA is 57.71 EUR. In the past month the price increased by 0.93%. In the past year, price increased by 24.86%.
ERF.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| DIM.PA | SARTORIUS STEDIM BIOTECH | 49.07 | 20.59B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 49.49 | 20.76B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 55.49 | 18.95B | ||
| SRT.DE | SARTORIUS AG | 42.76 | 14.60B | ||
| QIA.DE | QIAGEN N.V. | 19.53 | 8.64B | ||
| 1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 16.32 | 2.38B | ||
| EVT.DE | EVOTEC SE | N/A | 1.96B | ||
| GXI.DE | GERRESHEIMER AG | 6.76 | 861.77M | ||
| FF.MI | FINE FOODS & PHARMACEUTICALS | 10.47 | 205.60M | ||
| MLC.I | MALIN CORP PLC | N/A | 33.56M |
Related stock screener links
About ERF.PA
Company Profile
Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and, consumer products industries and to governments. The company operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain.
Company Info
EUROFINS SCIENTIFIC
23 Val Fleuri
Luxembourg LU
Employees: 62696
Phone: 35226185320
EUROFINS SCIENTIFIC / ERF.PA FAQ
What does EUROFINS SCIENTIFIC do?
Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and, consumer products industries and to governments. The company operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain.
Can you provide the latest stock price for EUROFINS SCIENTIFIC?
The current stock price of ERF.PA is 57.71 EUR. The price decreased by -1.89% in the last trading session.
What is the dividend status of EUROFINS SCIENTIFIC?
EUROFINS SCIENTIFIC (ERF.PA) has a dividend yield of 1.02%. The yearly dividend amount is currently 0.52.
How is the ChartMill rating for EUROFINS SCIENTIFIC?
ERF.PA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the growth outlook for EUROFINS SCIENTIFIC?
The Revenue of EUROFINS SCIENTIFIC (ERF.PA) is expected to grow by 5.07% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
When does EUROFINS SCIENTIFIC (ERF.PA) report earnings?
EUROFINS SCIENTIFIC (ERF.PA) will report earnings on 2026-01-28, after the market close.
ERF.PA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ERF.PA. When comparing the yearly performance of all stocks, ERF.PA turns out to be only a medium performer in the overall market: it outperformed 65.97% of all stocks.
ERF.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ERF.PA. ERF.PA has an average financial health and profitability rating.
ERF.PA Financial Highlights
Over the last trailing twelve months ERF.PA reported a non-GAAP Earnings per Share(EPS) of 3.6. The EPS increased by 16.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.44% | ||
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| Debt/Equity | 0.77 |
ERF.PA Forecast & Estimates
19 analysts have analysed ERF.PA and the average price target is 65.73 EUR. This implies a price increase of 13.9% is expected in the next year compared to the current price of 57.71.
For the next year, analysts expect an EPS growth of 14.43% and a revenue growth 5.07% for ERF.PA